Latest News

Apple jumped 3% on its first day under a new CEO, and the market fell anyway. When a rising trillion-dollar stock can't lift the indexes, look at the bond market.

Salesforce (NYSE:CRM) said its artificial intelligence product adoption is expanding across its customer base, with management highlighting growing demand for agentic workflows, consumption-based offerings and industry-specific AI applications during its Q2 fiscal 2027 investor webinar. Conor Marsd

Philip Morris has transformed from a declining tobacco play into a higher-margin, smoke-free growth story. Here's why I'm changing my mind on PM.

Abercrombie & Fitch shares have surged after record quarterly results and an Argus upgrade to Buy, though Citi downgraded the stock, citing a one-off tariff refund and stretched valuation.

Amazon trades at a 3.8x discount on price-to-sales, but Shopify's 30% revenue growth and zero debt tell a different growth story.

Brent crude climbs as U.S.-Iran tensions escalate, fueling a broad bond sell-off and inflation concerns today, Sept. 1, 2026.

The chips aren't just planned anymore. They're running and serving customers -- and an earlier agreement already puts a rough dollar figure on what comes next.

SK Hynix stock can go on a terrific bull run, driven by solid growth prospects and an attractive valuation.

This under-the-radar semiconductor company is now at the center of the AI revolution.

This option should be on your radar, especially if you claimed benefits early.

This little eVTOL maker still has plenty of upside potential.

September may be a historically weak month for stocks, but strong, verifiable AI-related results can still overpower the seasonal headwind.

What does 25 years of $200 monthly investments in the world's most boring ETF actually produce? The answer is more inspiring than you'd think.

Medtronic beat Q1 FY2027 estimates, raised guidance, and holds a Moderate Buy rating from analysts, with its 3%-plus dividend positioning it near Dividend King status.

The U.S. 10-year yield rose as high as 4.797% this morning, the highest since Jan. 14, 2025.

Disney stock soared 12% in August, but it's still trading lower in 2026. Wake me up when September ends.

Gainers bioAffinity Technologies (NASDAQ:BIAF) shares rose 43.1% to $6.53 during Tuesday's regular session. The company's market cap stands at $2.7 million. USBC (AMEX:USBC) stock moved upwards by 16.66% to

Gainers Reading Intl (NASDAQ:RDIB) stock moved upwards by 21.9% to $18.41 during Tuesday's regular session. The company's market cap stands at $345.6 million. FreeCast (NASDAQ:CAST) stock rose 11.32% to $1.43.

Gainers AEye (NASDAQ:LIDR) stock rose 33.1% to $1.53 during Tuesday's regular session. The market value of their outstanding shares is at $53.4 million. Focus Universal (NASDAQ:FCUV) stock increased by 14.21% to

Gainers Olenox Industries (NASDAQ:OLOX) stock increased by 26.9% to $1.26 during Tuesday's regular session. The company's market cap stands at $1.6 million. Greenwave Technology (NASDAQ:GWAV) stock rose 16.32%

Novartis stock spikes 5% on positive Phase 3 REMODEL trial results for relapsing MS drug remibrutinib with no liver safety signals.

The broader market might be near an all-time high, but some stocks are still trading at very attractive levels.

Kedia exercised vested stock options at $55.01 per share and immediately sold them at $62.37, retaining a direct stake of 426,262 shares worth approximately $26.6 million.

Travelling to or from the airport should be convenient, comfortable, and reliable. For passengers who want to avoid taxi queues, crowded public transport,

Medicine Packaging plays an important role in protecting pharmaceutical products, organizing essential information, and supporting proper handling. A well